CARL

Dopo l'orario di chiusura: 12.91

Carlsmed Inc (CARL)

Panoramica Notizia Cronologia dei prezzi Forum Previsione

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Carlsmed Inc Stock (CARL) Company Profile

Carlsmed Inc

Healthcare (1151)

858-295-9290

1800 ASTON AVENUE, CARLSBAD

Prossima data di guadagno

Ultimi documenti SEC

CARL's Discussions on Twitter

Confronta CARL con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
CARL Carlsmed Inc	12.91	359.64M	0	0	0	0.00
VEEV Veeva Systems Inc	270.06	44.25B	2.97B	809.93M	1.33B	4.87
TEM Tempus Ai Inc	78.12	13.61B	803.32M	-709.10M	-212.68M	-7.8003
DOCS Doximity Inc	68.52	12.55B	550.17M	201.35M	232.07M	1.00
HQY Healthequity Inc	97.70	7.68B	1.15B	96.70M	-161.99M	1.09
WAY Waystar Holding Corp	37.23	6.45B	906.14M	-52.62M	89.62M	-0.3621

Carlsmed Inc Stock (CARL) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-08-18	Iniziato	BTIG Research	Buy
2025-08-18	Iniziato	BofA Securities	Buy
2025-08-18	Iniziato	Goldman	Buy
2025-08-18	Iniziato	Piper Sandler	Overweight
2025-08-18	Iniziato	Truist	Buy

Carlsmed Inc Borsa (CARL) Ultime notizie

Carlsmed Inc Azioni (CARL) Dati Finanziari

Non sono disponibili dati finanziari per Carlsmed Inc (CARL). Controlla altri titoli per ulteriori informazioni.

Carlsmed Inc Azioni (CARL) insider trading

Commercio interno	Relazione	Data	Transazione	Costo	#Azioni	Valore ($)	#Azioni Totale
Sidow Kevin	Director	Jul 24 '25	Buy	15.00	13,333	199,995	59,566
Mittendorff Robert II	Director	Jul 24 '25	Buy	15.00	1,333,333	19,999,995	5,013,839
ROOT JONATHAN D	Director	Jul 24 '25	Buy	15.00	466,666	6,999,990	483,999
YOUNG PHILIP M	Director	Jul 24 '25	Buy	15.00	59,999	899,985	53,333

Carlsmed Inc (CARL)

Carlsmed Inc Stock (CARL) Company Profile

Confronta CARL con altri titoli

Carlsmed Inc Stock (CARL) Upgrades & Downgrades

Carlsmed Inc Borsa (CARL) Ultime notizie

Carlsmed initiated with Buy at Truist on business potential - MSN

Carlsmed Q2 2025 revenue up 99% to USD 12.1M - Medical Buyer

Carlsmed, Inc.: Strong Financial Performance and Growth Potential Justify Buy Rating - TipRanks

Carlsmed stock rating reiterated at Buy by Goldman Sachs on growth outlook - Investing.com

Carlsmed, Inc.: Strong Performance and Promising Growth Prospects with Upcoming Product Launch - TipRanks

Carlsmed Reports Strong Growth in Q2 2025 Earnings - TipRanks

Carlsmed 2025 Q2 Earnings Strong Revenue Growth Despite Widening Net Loss - AInvest

Carlsmed: A High-Growth AI-Driven MedTech Play in Spine Surgery - AInvest

UPDATECarlsmed® Reports Second Quarter 2025 Financial Results - The Manila Times

Earnings call transcript: Carlsmed’s Q2 2025 revenue surges, stock rises - Investing.com

Carlsmed Q2 Loss Narrows, Revenue Rises - MarketScreener

Carlsmed reports second quarter 2025 financial results - MarketScreener

Carlsmed® Q2 2025 Financial Performance: Assessing Long-Term Growth Potential in the AI-Driven Spine Surgery Revolution - AInvest

CARLSMED, INC. SEC 10-Q Report - TradingView

Carlsmed, Inc.'s Q2 2025 Performance and Strategic Momentum: A Disruptive Force in AI-Driven Spine Surgery - AInvest

Carlsmed® Reports Second Quarter 2025 Financial Results - MarketScreener

99% Growth: AI Spine Surgery Pioneer Carlsmed Hits $12.1M Revenue, Expands into Cervical Procedures - Stock Titan

Carlsmed CARL 2025Q2 Earnings Preview Upside Potential on AI-Driven Spine Solutions - AInvest

Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail

Truist Securities initiates coverage on Carlsmed stock with Buy rating By Investing.com - Investing.com Australia

Why Is Carlsmed Stock Gaining Monday?Carlsmed (NASDAQ:CARL) - Benzinga

AI medtech firm Carlsmed prices $100.5M IPO - MSN

Truist Initiates Buy on Carlsmed with Focus on Business Growth Potential - AInvest

Carlsmed initiated with Buy at Truist on business potential (CARL) - Seeking Alpha

BofA Securities Initiates Coverage on Carlsmed With Buy Rating, $16 Price Target - MarketScreener

This Synaptics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga

Goldman Sachs Initiates Coverage on Carlsmed With Buy Rating, $19 Price Target - MarketScreener

Carlsmed initiated with a Buy at BTIG - TipRanks

Truist Securities initiates coverage on Carlsmed stock with Buy rating - Investing.com

Truist Initiates Carlsmed at Buy With $18 Price Target - MarketScreener

Piper Sandler initiates coverage on Carlsmed with an Overweight rating, PT of $18. - AInvest

Buy Rating for Carlsmed: Innovative Aprevo Technology and Strong Growth Projections Justify Premium Valuation - TipRanks

Carlsmed stock initiated with Buy rating at BTIG on customized implant tech - Investing.com

Carlsmed stock initiated with Buy rating at BTIG on customized implant tech By Investing.com - Investing.com South Africa

Carlsmed initiated with an Overweight at Piper Sandler - TipRanks

Piper Sandler initiates Carlsmed stock with Overweight rating on custom implant potential - Investing.com India

Goldman Sachs initiates coverage on Carlsmed stock with Buy rating - Investing.com

Goldman Sachs initiates coverage on Carlsmed stock with Buy rating By Investing.com - Investing.com Nigeria

Carlsmed initiated with a Buy at Goldman Sachs - MSN

Carlsmed Stock Down 6% Since IPO But Goldman Bullish And Predicts 35% Upside Potential — Retail Traders Stay Bearish - Stocktwits

AI medtech firm Carlsmed to sell 6.7M shares in IPO - MSN

Carlsmed, Inc. shares fall 2.01% after-hours as it prepares to report Q2 2025 financial results. - AInvest

Carlsmed Inc. to Report Second Quarter 2025 Financial Results on August 28, 2025 - The Manila Times

Carlsmed to report Q2 2025 financial results on Aug 28, 2025. - AInvest

Big Boost for Personalized Cervical Fusion: Add-On Code - Orthopedics This Week

Heartflow raises $317M, pops 66% at market open - BioWorld MedTech

Med-tech funding rebounds modestly to $18B through July - BioWorld MedTech

Carlsmed’s $100.5M IPO fuels 3D printed spinal implants growth - 3D Printing Industry

Carlsmed’s aprevo implants receive CMS NTAP for cervical fusion procedures - TipRanks

Carlsmed’s aprevo® Personalized Interbody Implants Receive CMS New Technology Add-On Payment (NTAP) for Cervical Fusion Procedures - Ortho Spine News

Carlsmed's Aprevo Implants Receive CMS NTAP Approval For Cervical Fusion Procedures Under FY2026 IPPS Final Rule - 富途牛牛

Carlsmed Inc Azioni (CARL) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Carlsmed Inc Azioni (CARL) insider trading

Simile a CARL